Patents by Inventor Faical Miyara

Faical Miyara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-PD-1 Antibodies and Fusion Proteins
    Publication number: 20230416363
    Abstract: Provided herein are recombinant antibodies, antigen-binding fragments, and fusion proteins thereof useful for binding to and inhibiting programmed death 1 (PD-1), nucleic acid molecules encoding the same and therapeutic compositions thereof, as well as methods of using such antibodies, including the methods for enhancing T cell and NK cell function to increase cell and cytokine mediated immunity and methods of treatment of various immune dysfunction related disorders including cancer and infectious diseases.
    Type: Application
    Filed: June 23, 2021
    Publication date: December 28, 2023
    Applicant: Kadmon Corporation, LLC
    Inventors: Dan Lu, Zhanna Polonskaya, Tzu-Pei Chang, Stella Aviaty Martomo, Jeegar P. Patel, Faical Miyara
  • B7-H4 Antibodies and Anti-B7-H4 Antibody/IL-15 Fusion Proteins
    Publication number: 20230312724
    Abstract: Provided herein are recombinant antibodies, antigen-binding fragments thereof, and fusion proteins thereof useful for binding to and inhibiting B7-H4. Also provided are nucleic acid molecules encoding the antibodies, antigen-binding fragments thereof, and fusion proteins thereof disclosed herein and therapeutic compositions thereof. Disclosed are further methods of using the disclosed antibodies, antigen-binding fragments thereof, and fusion proteins thereof for the treatment of disease.
    Type: Application
    Filed: November 29, 2022
    Publication date: October 5, 2023
    Applicant: Kadmon Corporation, LLC
    Inventors: Dan Lu, Jeegar P. Patel, Tzu-Pei Chang, Zhanna Polonskaya, Faical Miyara
  • ANTI-GD3 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
    Publication number: 20190048073
    Abstract: The present invention provides for anti-GD3 antibodies, and ADCs and methods for preparing and using the same.
    Type: Application
    Filed: July 19, 2018
    Publication date: February 14, 2019
    Inventors: Faical Miyara, Dhanvanthri S Deevi, Lioudmila Tchistiakov, Michelle Mader, Yijie Gao, Paul Chapman, Govind Ragupathi